Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2007-08-07
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C548S454000
Reexamination Certificate
active
10539515
ABSTRACT:
Benzodioxepines of the formula (I) and physiologically tolerated salts and solvates thereof, in which R1, R2, R3, R4, A, B, a and b have the meanings indicated in claim 1, are ligands of the 5HT1A receptors and/or the 5HT4 receptors with simultaneously strong serotonin reuptake inhibition. They can be employed for the treatment and prophylaxis of various diseases
REFERENCES:
patent: 3944560 (1976-03-01), Wasson et al.
patent: 0 769 496 (1997-04-01), None
patent: 2 007 656 (1979-05-01), None
patent: WO 03 87086 (2003-10-01), None
Bartoszyk Gerd
Berthelon Jean
Böttcher Henning
Brunet Michel
Greiner Hartmut
Barker Michael P.
McKane Joseph K.
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
LandOfFree
Substituted benzodioxepines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzodioxepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzodioxepines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3866277